Cargando…

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia

BACKGROUND: Artemisinin resistance is associated with delayed parasite clearance half-life in vivo and correlates with ring-stage survival under dihydroartemisinin in vitro. Both phenotypes are associated with mutations in the PF3D7_1343700 pfkelch13 gene. Recent spread of artemisinin resistance and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Angana, Bopp, Selina, Magistrado, Pamela, Wong, Wesley, Daniels, Rachel, Demas, Allison, Schaffner, Stephen, Amaratunga, Chanaki, Lim, Pharath, Dhorda, Mehul, Miotto, Olivo, Woodrow, Charles, Ashley, Elizabeth A., Dondorp, Arjen M., White, Nicholas J., Wirth, Dyann, Fairhurst, Rick, Volkman, Sarah K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427620/ https://www.ncbi.nlm.nih.gov/pubmed/28494763 http://dx.doi.org/10.1186/s12936-017-1845-5

Ejemplares similares

Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
por: Bopp, Selina, et al.
Publicado: (2018)

Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination
por: Dhorda, Mehul, et al.
Publicado: (2021)

Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum
por: Sharma, Aabha I., et al.
Publicado: (2020)

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility
por: Demas, Allison R., et al.
Publicado: (2018)

Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
por: Tindana, Paulina, et al.
Publicado: (2022)

Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study
por: de Haan, Freek, et al.
Publicado: (2022)

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023)

Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives
por: O’Flaherty, Katherine, et al.
Publicado: (2019)

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
por: Miotto, Olivo, et al.
Publicado: (2013)

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
por: de Haan, Freek, et al.
Publicado: (2021)

Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
por: Srimuang, Krongkan, et al.
Publicado: (2016)

Correction to: Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
por: Srimuang, Krongkan, et al.
Publicado: (2018)

Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.
por: Tindana, Paulina, et al.
Publicado: (2021)

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria
por: Intharabut, Benjamas, et al.
Publicado: (2019)

Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia
por: Cutts, Julia C, et al.
Publicado: (2022)

Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda
por: Zupko, Robert J., et al.
Publicado: (2023)

Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
por: Cao, Van Anh Thi, et al.
Publicado: (2023)

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
por: Maude, Richard J, et al.
Publicado: (2009)

Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa
por: St. Laurent, Brandyce, et al.
Publicado: (2015)

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria
por: Mokuolu, Olugbenga Ayodeji, et al.
Publicado: (2023)

Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
por: de Haan, Freek, et al.
Publicado: (2023)

Corrigendum: Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa
por: St. Laurent, Brandyce, et al.
Publicado: (2016)

Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal
por: Diallo, Mamadou Alpha, et al.
Publicado: (2020)

Ex vivo RSA and Pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017
por: Yade, Mamadou Samb, et al.
Publicado: (2023)

Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017
por: Yade, Mamadou Samb, et al.
Publicado: (2023)

α(+)Thalassemia Antagonizes the Malaria-protective Effects of Sickle-Cell Trait
por: Amaratunga, Chanaki, et al.
Publicado: (2014)

The Cambodia Research Consortium: expediting research for malaria elimination with the emergency response to artemisinin resistance framework
por: Canavati, Sara E., et al.
Publicado: (2016)

Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
por: Amato, Roberto, et al.
Publicado: (2018)

Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study
por: Tun, Kyaw Myo, et al.
Publicado: (2016)

Pfkelch13 Plasmodium falciparum Mutations in Huambo, Angola
por: Rodrigues, Ana Beatriz Batista, et al.
Publicado: (2022)

Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance
por: Maude, Richard J., et al.
Publicado: (2012)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
por: Zhu, Lei, et al.
Publicado: (2022)

Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites
por: Rocamora, Frances, et al.
Publicado: (2018)

The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
por: Imwong, Mallika, et al.
Publicado: (2017)

Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia
por: Tripura, Rupam, et al.
Publicado: (2017)

Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia
por: Duanguppama, Jureeporn, et al.
Publicado: (2019)

Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples
por: Venkatesan, Meera, et al.
Publicado: (2012)

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
por: Ringwald, Pascal, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2bc8to23bvdbame8qmtggohf1f